General
Glaxo Smith Kline (BIOC.CA) - Corporate Governance Report
Published at 4 May 2026 at 10:56Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Corporate Governance Report for the year ended on 31/12/2025.
The Corporate Governance Report in Arabic (5,166 KB)
The Corporate Governance Report in English (6,745 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Corporate Governance Report for the year ended on 31/12/2025.
The Corporate Governance Report in Arabic (5,166 KB)
The Corporate Governance Report in English (6,745 KB)